Literature DB >> 4974763

Transfer of cephaloridine from mother to fetus.

L J Arthur, W L Burland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4974763      PMCID： PMC2020218          DOI： 10.1136/adc.44.233.82

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  4 in total

1.  PENICILLINASE-RESISTANT PENICILLINS AND CEPHALOSPORINS.

Authors:  M BARBER; P M WATERWORTH
Journal:  Br Med J       Date:  1964-08-08

2.  Placental transmission of cephaloridine.

Authors:  W Barr; R M Graham
Journal:  J Obstet Gynaecol Br Commonw       Date:  1967-10

3.  Cephaloridine treatment of bacterial infections.

Authors:  M A Apicella; R L Perkins; S Saslaw
Journal:  Am J Med Sci       Date:  1966-03       Impact factor: 2.378

4.  Cephaloridine activity in vitro and absorption and urinary excretion in normal young men.

Authors:  J W Kislak; B W Steinhauer; M Finland
Journal:  Am J Med Sci       Date:  1966-04       Impact factor: 2.378
  4 in total
  5 in total

1.  Transfer of a new cephalosporin antibiotic to the foetus and the amniotic fluid during a continuous infusion (steady state) and single repeated intravenous injections to the mother.

Authors:  H A Hirsch; S Herbst; R Lang; L Dettli; A Gablinger
Journal:  Arch Gynakol       Date:  1974-01-04

Review 2.  Cephalosporins in urinary tract infection.

Authors:  L O Gentry
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 3.  Placental transfer of drugs administered to the mother.

Authors:  G M Pacifici; R Nottoli
Journal:  Clin Pharmacokinet       Date:  1995-03       Impact factor: 6.447

4.  Ceftriaxone distribution between maternal blood and fetal blood and tissues at parturition and between blood and milk postpartum.

Authors:  D A Kafetzis; D C Brater; J E Fanourgakis; J Voyatzis; P Georgakopoulos
Journal:  Antimicrob Agents Chemother       Date:  1983-06       Impact factor: 5.191

Review 5.  Review of beta-lactam antibiotics in pregnancy. The need for adjustment of dosage schedules.

Authors:  A Heikkilä; R Erkkola
Journal:  Clin Pharmacokinet       Date:  1994-07       Impact factor: 6.447
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.